The Crucial Role of 2,5-Dibromobenzene-1,4-diol in Pharmaceutical Synthesis
For R&D scientists and procurement managers in the pharmaceutical industry, identifying reliable sources for high-quality chemical intermediates is paramount. One such critical compound is 2,5-Dibromobenzene-1,4-diol (CAS 14753-51-6). This brominated aromatic diol serves as a fundamental building block in the complex synthesis pathways of various active pharmaceutical ingredients (APIs) and advanced drug molecules. Understanding its properties and how to procure it effectively can significantly impact research timelines and production efficiency.
Understanding 2,5-Dibromobenzene-1,4-diol
2,5-Dibromobenzene-1,4-diol, also known by synonyms like 2,5-dibromohydroquinone, is typically supplied as a white to light yellow or light orange powder. Its molecular formula is C6H4Br2O2, with a molecular weight of approximately 267.90 g/mol. A key specification for its use in pharmaceutical synthesis is its purity, often required to be 97% min. The compound’s melting point, typically between 191-194°C, is another critical indicator of its quality and consistency. These specifications are crucial for ensuring predictable reaction outcomes in the synthesis of complex pharmaceutical compounds.
Key Applications in Pharmaceutical Development
The reactivity introduced by the two bromine atoms and the hydroxyl groups on the benzene ring makes 2,5-Dibromobenzene-1,4-diol an exceptionally versatile intermediate. It can undergo various coupling reactions, substitutions, and functional group transformations, paving the way for the creation of intricate molecular architectures. Pharmaceutical researchers utilize this compound to construct specific scaffolds that form the core of potential drug candidates targeting a wide range of diseases. Its role as a starting material or intermediate means that the quality and availability of 2,5-Dibromobenzene-1,4-diol directly influence the success of drug discovery and development programs. For those looking to buy 2,5-dibromobenzene-1,4-diol for their pharmaceutical projects, ensuring it meets rigorous quality standards is non-negotiable.
Sourcing and Procurement Considerations
When sourcing chemical intermediates like 2,5-Dibromobenzene-1,4-diol, several factors come into play. The ability to secure a consistent supply from a reputable manufacturer in China is often a strategic advantage, providing access to competitive pricing and substantial production capacities. Procurement managers often look for suppliers who can offer not only the chemical itself but also detailed specifications, certificates of analysis (CoA), and responsive customer service. Exploring options for high purity 2,5-dibromobenzene-1,4-diol price quotations from established chemical suppliers can help in budgeting and resource allocation for ongoing projects. As a vital pharmaceutical intermediate CAS 14753-51-6 supplier, partnering with a reliable entity ensures the integrity of your supply chain.
In conclusion, 2,5-Dibromobenzene-1,4-diol is an indispensable component in the chemical arsenal of pharmaceutical researchers and manufacturers. Its unique chemical structure and high purity make it a sought-after intermediate. For any organization involved in drug discovery or development, securing a dependable source for this compound is a critical step towards achieving successful outcomes. Engage with leading suppliers to obtain the quality and quantity required for your next breakthrough.
Perspectives & Insights
Alpha Spark Labs
“It can undergo various coupling reactions, substitutions, and functional group transformations, paving the way for the creation of intricate molecular architectures.”
Future Pioneer 88
“Pharmaceutical researchers utilize this compound to construct specific scaffolds that form the core of potential drug candidates targeting a wide range of diseases.”
Core Explorer Pro
“Its role as a starting material or intermediate means that the quality and availability of 2,5-Dibromobenzene-1,4-diol directly influence the success of drug discovery and development programs.”